Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
03/2006
03/16/2006US20060058552 Solid preferably with an aspect ratio of 1 to 4 and a solubility in water at room temperature of at least 425 mg/ml.
03/16/2006US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase
03/16/2006US20060058307 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
03/16/2006US20060058304 Azaindole kinase inhibitors
03/16/2006US20060058300 Intermediates of bupropion metabolites synthesis
03/16/2006US20060058288 Severe sepsis preventive therapeutic agent
03/16/2006US20060057649 Screening method and anti-tumor drug candidate obtained therefrom
03/16/2006US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
03/16/2006US20060057132 Identifying and treating vaginal infections
03/16/2006DE202006000487U1 Preparation useful for, e.g. stimulating copulation in animals such as cow and poultry and as feed, comprises whole plants (Mucuna pruriens fruits, Glycyrrhiza glabra and Withania somniferum) and flavorants with or without dextrose
03/16/2006CA2579775A1 Truncated lhrh formulations
03/16/2006CA2519418A1 New injectable formulations containing progesterone
03/15/2006EP1634953A2 Platelet-activating factor acethylhydrolase
03/15/2006EP1634883A1 2-substituted phenyl-5,7-dialkyl-3,7-dihydropyrrole[2,3-d]pyrimidine-4-one derivatives, the preparation and the pharmaceutical use thereof
03/15/2006EP1634602A2 Use of plants of the genus Sideritis for preventing and influencing disturbances correlated with a changed serotoninergic neurotransmission
03/15/2006EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
03/15/2006EP1633389A1 Unitary combination of fsh and hcg
03/15/2006EP1470155B1 Pluripotency determining factor and uses thereof
03/15/2006EP1444206B1 Substituted benzo[b]azepin-2-one compounds as analgesics
03/15/2006EP1390039B1 Use of estrogen compounds to increase libido in women
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006EP1296679B1 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition
03/15/2006EP1140044B1 cGMP PDE 5 INHIBITORS FOR INHALATION IN THE TREATMENT OF SEXUAL DYSFUNCTION
03/15/2006EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
03/15/2006CN1747736A Compositon comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
03/15/2006CN1746171A Heterocyclic hepyramine derivative, its preparation and use thereof
03/15/2006CN1745840A Chinese medicinal capsule for treating metrorrhagia and metrostaxis
03/15/2006CN1745837A Funing preparation and its making method theref
03/15/2006CN1745831A Chinese medicine for treating prostatitis, impotence and premature ejaculation, its preparation
03/15/2006CN1745809A Liuwei Dihuang effervescent tablet and its preparation thereof
03/15/2006CN1745807A Tablet for treating difficult menstruation and its preparation
03/15/2006CN1745797A Medicine for treating menstrual irregularities and menalgia
03/15/2006CN1745786A Zhimiling preparation and its making method thereof
03/15/2006CN1745775A Medicine with kidney warming and Yang tonifying functions and its preparation thereof
03/15/2006CN1745765A Fuyanping preparation and its making method thereof
03/15/2006CN1745763A Kunjing preparation and its making method thereof
03/15/2006CN1245402C Indole derivatives, their preparation, medicinal compositions containing them and use thereof
03/15/2006CN1245210C Ready made traditional Chinese medicine for treating hyperplasia of mammary gland
03/15/2006CN1245196C Preparation method of novel concentrated pill of black-bone chicken
03/15/2006CN1245192C Lactation and blood-tonifying oral liquid and its preparation method
03/15/2006CN1245191C Pelvic inflammation-treating traditional Chinese medicinal preparation
03/15/2006CN1245190C Hemiplegia hypertension and contraceptive treating plaster
03/15/2006CN1245189C Composition for strengthening body resistance and restoring and function, strengthening spleen and kidney, relieving mental stress and promoting blood circulation to remove blood stasis
03/15/2006CN1245188C Yi-E-Jing tablets for nourishing kidney and tonifying yang
03/15/2006CN1245182C Medicine for treating barrenness
03/15/2006CN1245171C Yi-E-Jing pills for tonifying yang
03/14/2006US7012146 Modulators of all three classes of calcium channel blocker subtypes (Small, Intermediate and Big conductance K channel (SK, IK and BK)) comprising malonate esters and nitriles; respiratory, brain, cardiovascular, urogenital disorders
03/14/2006US7012145 Method
03/14/2006US7012089 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist
03/14/2006US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction
03/14/2006US7012084 Acylated piperidine derivatives as melanocortin-4 receptor agonists
03/14/2006US7011825 Erythropoietin solution preparation
03/14/2006US7011820 Delivery of compounds for the treatment of Parkinsons through an inhalation route
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/14/2006CA2295515C Method for large-scale production of di(uridine 5'-tetraphosphate) and salts thereof
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
03/14/2006CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods
03/14/2006CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors
03/09/2006WO2006025490A1 Molecular chaperone function regulator
03/09/2006WO2006024931A2 Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
03/09/2006WO2006024121A1 Use of n-phenylpiperazine derivatives and pharmaceutical compositions containing them
03/09/2006US20060052594 New corticosteroids
03/09/2006US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
03/09/2006US20060052458 Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
03/09/2006US20060052435 Selective dopamin d3 receptor agonists for the treatment of sexual dysfunction
03/09/2006US20060052406 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
03/09/2006US20060052397 Compounds for trearment of cardiovascular disorders and hypotensive agents
03/09/2006US20060052396 Arylamines for the treatment of conditions associated with gsk-3
03/09/2006US20060052388 Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
03/09/2006US20060052341 Control of a biological function
03/09/2006US20060052323 Method to inhibit cell growth using oligonucleotides
03/09/2006US20060051863 Meiosis arrest in human oocytes in vitro
03/09/2006US20060051433 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs
03/09/2006DE19681616B4 Prozeß zur Gewinnung von Oestrogenen aus Stutenharn Process for the production of estrogens from Stutenharn
03/09/2006DE102004040630A1 Kombinationstherapie mit Procain Combination therapy with procaine
03/09/2006CA2577928A1 Molecular chaperone function regulator
03/09/2006CA2577613A1 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof
03/08/2006EP1632471A1 Racemic and optically pure metabolites of Sibutramine, their preparation, compositions comprising them and their use as Dopamine reuptake inhibitors
03/08/2006EP1632237A2 Compositions comprising drospirenone and a complex between ethinyl-estradiol and a cyclodextrin
03/08/2006EP1631255A2 Drug delivery system
03/08/2006EP1631243A2 Sexual hygienic composition
03/08/2006EP1505997B1 Formulations useful in the treatment of male and female impotence
03/08/2006EP1503775B1 Formulations useful in the treatment of male and female impotence
03/08/2006EP1492781B1 N,n'-disubstituted piperazine compounds and the use of the same as analgesics
03/08/2006EP1448592B1 Steroidal compounds for inhibiting steroid sulphatase
03/08/2006EP1423407B1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
03/08/2006EP1406628B1 Tetrahydroquinoline derivatives
03/08/2006EP1404667B1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/08/2006EP1347966B1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
03/08/2006EP1343784B1 UREA SUBSTITUTED IMIDAZOQUINOLINE ETHERS and pharmaceutical compositions comprising the same.
03/08/2006EP1294389B1 Therapeutical use of sophora flavescens or sophora subprostrata extracts
03/08/2006EP1276722B1 Naphthamidine urokinase inhibitors
03/08/2006EP1237565B1 Betaglycan as an inhibin receptor and uses thereof
03/08/2006EP1038011B1 Methods of producing anti-angiogenic proteins; endostatin, angiostatin or restin, using a pichia yeast expression system
03/08/2006EP1032662B1 Methods and compositions for immunomodulation
03/08/2006EP1003774B1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
03/08/2006EP0954298B1 2,5-dihydroxybenzenesulfonic derivatives for the treatment of sexual dysfunction
03/08/2006CN1745080A 1,3-dihydroimidazole fused-ring compound
03/08/2006CN1745074A 5-HT receptor ligands and uses thereof
03/08/2006CN1744891A Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of EDHF function